Biocorp Production Future Growth

Future criteria checks 5/6

Biocorp Production is forecast to grow earnings and revenue by 136.3% and 47.9% per annum respectively while EPS is expected to grow by 136.8% per annum.

Key information

136.3%

Earnings growth rate

136.8%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate47.9%
Future return on equityn/a
Analyst coverage

Low

Last updated11 Oct 2023

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:8BP - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025451810N/A1
12/31/20242410N/A1
12/31/2023190-2N/A1
6/30/202313-2N/AN/AN/A
3/31/202312-1N/AN/AN/A
12/31/202212-1-10N/A
9/30/202211-1-10N/A
6/30/202210-1-11N/A
3/31/2022100-10N/A
12/31/2021100-10N/A
9/30/20219-1-3-1N/A
6/30/20218-2-4-2N/A
3/31/20218-1-3-1N/A
12/31/20208-1-30N/A
9/30/20208-1-11N/A
6/30/20207-113N/A
3/31/20208012N/A
12/31/20198112N/A
9/30/201980-2-1N/A
6/30/20197-1-5-4N/A
3/31/20196-3-5-5N/A
12/31/20184-5-6-5N/A
9/30/20184-6-5-4N/A
6/30/20183-8-4-4N/A
3/31/20183-8-5-4N/A
12/31/20172-8-5-4N/A
9/30/20172-6-5-4N/A
6/30/20172-5-5-4N/A
3/31/20173-5N/A-4N/A
12/31/20163-4N/A-3N/A
9/30/20163-4N/A-3N/A
6/30/20163-4N/A-3N/A
3/31/20163-2N/A-3N/A
12/31/20153-1N/A-3N/A
12/31/201420N/A-1N/A
12/31/201320N/AN/AN/A
12/31/20122N/AN/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 8BP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.4%).

Earnings vs Market: 8BP is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 8BP is expected to become profitable in the next 3 years.

Revenue vs Market: 8BP's revenue (47.9% per year) is forecast to grow faster than the German market (4.6% per year).

High Growth Revenue: 8BP's revenue (47.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 8BP's Return on Equity is forecast to be high in 3 years time


Discover growth companies